Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Sell
49
VC Quote, Financials, Valuation and Earnings
Last price:
$92.15
Seasonality move
:
4.06%
Day range:
$88.69 - $90.65
52-week range:
$65.10 - $117.94
Dividend yield:
0%
P/E ratio:
8.48x
P/S ratio:
0.65x
P/B ratio:
1.88x
Volume:
698.7K
Avg. volume:
328.3K
1-year change:
-15.46%
Market cap:
$2.5B
Revenue:
$3.9B
EPS (TTM):
$10.67
Analysts' Opinion
-
Consensus RatingVisteon has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $93.08, Visteon has an estimated upside of 2.85% from its current price of $90.45.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $82.00 representing 100% downside risk from its current price of $90.45.
Fair Value
-
According to the consensus of 14 analysts, Visteon has 2.85% upside to fair value with a price target of $93.08 per share.
VC vs. S&P 500
-
Over the past 5 trading days, Visteon has underperformed the S&P 500 by -2.49% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Visteon does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Visteon has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Visteon reported revenues of $934M.
Earnings Growth
-
Visteon has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Visteon reported earnings per share of $2.36.
Enterprise value:
2.2B
EV / Invested capital:
1.29x
Price / LTM sales:
0.65x
EV / EBIT:
6.43x
EV / Revenue:
0.57x
PEG ratio (5yr expected):
0.02x
EV / Free cash flow:
7.55x
Price / Operating cash flow:
8.59x
Enterprise value / EBITDA:
4.99x
Gross Profit (TTM):
$550M
Return On Assets:
10.44%
Net Income Margin (TTM):
7.68%
Return On Equity:
23.53%
Return On Invested Capital:
18.73%
Operating Margin:
9.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $3.9B | $3.9B | $3.9B | $933M | $934M | |
| Gross Profit | $402M | $496M | $550M | $119M | $138M | |
| Operating Income | $206M | $289M | $348M | $67M | $91M | |
| EBITDA | $322M | $381M | $443M | $89M | $123M | |
| Diluted EPS | $4.75 | $17.37 | $10.67 | $1.50 | $2.36 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | $1.5B | $1.7B | $1.6B | $1.7B | |
| Total Assets | $2.2B | $2.2B | $2.4B | $2.7B | $3B | |
| Current Liabilities | $775M | $849M | $964M | $938M | $927M | |
| Total Liabilities | $1.7B | $1.6B | $1.6B | $1.6B | $1.6B | |
| Total Equity | $506M | $642M | $807M | $1.1B | $1.4B | |
| Total Debt | $349M | $349M | $352M | $332M | $315M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $169M | $355M | $428M | $69M | $70M | |
| Cash From Investing | -$67M | -$140M | -$185M | -$37M | -$33M | |
| Cash From Financing | -$10M | -$182M | -$87M | -$31M | -$18M | |
| Free Cash Flow | $88M | $214M | $293M | $32M | $35M | |
VC
Sector
Market Cap
$2.5B
$420M
Price % of 52-Week High
76.73%
71.56%
Dividend Yield
0%
0%
Shareholder Yield
2.56%
4.03%
1-Year Price Total Return
-13.88%
-11.11%
Beta (5-Year)
1.195
0.780
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$91.05
200-day SMA
Buy
Level
$86.84
Bollinger Bands (100)
Buy
Level
76.52 - 88.1
Chaikin Money Flow
Buy
Level
3.3M
20-day SMA
Buy
Level
$87.03
Relative Strength Index (RSI14)
Buy
Level
59.36
ADX Line
Buy
Level
26.41
Williams %R
Neutral
Level
-21.1506
50-day SMA
Buy
Level
$82.39
MACD (12, 26)
Buy
Level
2.28
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
52.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1762)
Buy
CA Score
(Annual)
Level (0.1502)
Buy
Beneish M-Score
(Annual)
Level (-2.7814)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.0999)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company’s reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.
Stock Forecast FAQ
In the current month, VC has received 5 Buy ratings 9 Hold ratings, and 0 Sell ratings. The VC average analyst price target in the past 3 months is $93.08.
-
Where Will Visteon Stock Be In 1 Year?
According to analysts, the consensus estimate is that Visteon share price will rise to $93.08 per share over the next 12 months.
-
What Do Analysts Say About Visteon?
Analysts are divided on their view about Visteon share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Visteon is a Sell and believe this share price will drop from its current level to $82.00.
-
What Is Visteon's Price Target?
The price target for Visteon over the next 1-year time period is forecast to be $93.08 according to 14 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is VC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Visteon is a Hold. 9 of 14 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of VC?
You can purchase shares of Visteon via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Visteon shares.
-
What Is The Visteon Share Price Today?
Visteon was last trading at $92.15 per share. This represents the most recent stock quote for Visteon. Yesterday, Visteon closed at $90.45 per share.
-
How To Buy Visteon Stock Online?
In order to purchase Visteon stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Howard Marks Buy Grab Stock?
When a legendary value investor who cut his teeth in…
Why Did Warren Buffett Buy Amazon Stock?
When investors think of tech stocks in Warren Buffett’s portfolio,…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
88
CDTX alert for Jun 24
Cidara Therapeutics [CDTX] is up 3.18% over the past day.
Sell
46
HIMS alert for Jun 24
Hims & Hers Health [HIMS] is up 2.26% over the past day.
Buy
67
WGS alert for Jun 24
GeneDx Holdings [WGS] is up 13.99% over the past day.
